Glycyrrhetinic Acid Inhibits Malignant Progression of Hepatocellular Carcinoma by Inducing Autophagy and Regulating Macrophage Polarization via the TGF-β1/SMAD Pathway
Hepatitis Monthly · 21.04.2026 · 26 (1)
DOI: 10.5812/hepatmon-169009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatitis Monthly, online erschienen am 21.04.2026. Verfasst von Youjin Wang und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) is one of the most aggressive malignancies, and its poor prognosis is primarily attributed to its complex tumor microenvironment (TME). Glycyrrhetinic acid (GA) possesses potent anti-tumor properties, but its mechanisms of action and molecular targets within the HCC microenvironment remain to be thoroughly explored.
Methods
Methods: This study employed HCC cell lines and a mouse xenograft model. In vitro experiments, we evaluated the effects of GA on HCC cell proliferation, migration, invasion, and apoptosis, and analyzed its role in M2 macrophage polarization within a co-culture system. Interventions using the autophagy inhibitor chloroquine (CQ) and the TGF-β1 signaling pathway activator SRI-011381 were performed, and the expression levels of autophagy markers, M1/M2 macrophage markers, and TGF-β1/SMAD pathway-related proteins were detected. In vivo experiments, we assessed the effects of GA on tumor progression, autophagy processes, and M2 macrophage infiltration.
Results
In vitro, GA significantly inhibited malignant behaviors of HCC cells and promoted their apoptosis and autophagy. Furthermore, GA treatment effectively blocked M2 macrophage polarization and their pro-tumorigenic function in the co-culture system, an effect that was significantly reversed by CQ. Regarding the molecular mechanism, GA was found to inhibit the activation of the TGF-β1/SMAD axis, and the TGF-β1 pathway activator SRI-011381 reversed GA's induction of autophagy and inhibition of M2 polarization. In animal experiments, GA treatment significantly suppressed tumor growth and promoted cell apoptosis; concurrently, GA promoted autophagy and reduced M2 macrophage infiltration in tumor tissues. All these effects were reversible by SRI-011381.
Conclusions
Glycyrrhetinic acid inhibits HCC malignant progression by suppressing the TGF-β1/SMAD axis, inducing autophagy in HCC cells, and inhibiting M2 macrophage polarization
Zitieren
APA
Wang, Y., Guan, H., & Duan, P. (2026). Glycyrrhetinic Acid Inhibits Malignant Progression of Hepatocellular Carcinoma by Inducing Autophagy and Regulating Macrophage Polarization via the TGF-β1/SMAD Pathway. Hepatitis Monthly, 26(1). https://doi.org/10.5812/hepatmon-169009
Vancouver
Wang Y, Guan H, Duan P. Glycyrrhetinic Acid Inhibits Malignant Progression of Hepatocellular Carcinoma by Inducing Autophagy and Regulating Macrophage Polarization via the TGF-β1/SMAD Pathway. Hepatitis Monthly. 2026;26(1). doi:10.5812/hepatmon-169009
BibTeX
@article{Wang2026,
author = {Wang, Youjin and Guan, Huiyun and Duan, Peibei},
title = {Glycyrrhetinic Acid Inhibits Malignant Progression of Hepatocellular Carcinoma by Inducing Autophagy and Regulating Macrophage Polarization via the TGF-β1/SMAD Pathway},
journal = {Hepatitis Monthly},
year = {2026},
volume = {26},
number = {1},
doi = {10.5812/hepatmon-169009}
}
EUVIMED